{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:54:10Z","timestamp":1793224450050,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1136\/ard.2007.069831","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:58:19Z","timestamp":1181350699000},"page":"1137-1142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":472,"title":["Vitamin D and autoimmunity: new aetiological and therapeutic considerations"],"prefix":"10.1016","volume":"66","author":[{"given":"Yoav","family":"Arnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Amital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.069831_bib1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1196\/annals.1351.031","article-title":"Predicting and preventing autoimmunity, myth or reality?","volume":"1069","author":"Harel","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1136\/ard.2007.069831_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S8756-3282(03)00030-9","article-title":"Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone","volume":"32","author":"Van Etten","year":"2003","journal-title":"Bone"},{"key":"10.1136\/ard.2007.069831_bib3","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1172\/JCI115072","article-title":"1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis","volume":"87","author":"Lemire","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2007.069831_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/jn\/128.1.68","article-title":"1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis","volume":"128","author":"Cantorna","year":"1998","journal-title":"J Nutr"},{"key":"10.1136\/ard.2007.069831_bib5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF00403372","article-title":"Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3","volume":"37","author":"Mathieu","year":"1994","journal-title":"Diabetologia"},{"key":"10.1136\/ard.2007.069831_bib6","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/jn\/130.11.2648","article-title":"1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease","volume":"130","author":"Cantorna","year":"2000","journal-title":"J Nutr"},{"key":"10.1136\/ard.2007.069831_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0090-1229(90)90005-B","article-title":"In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis","volume":"54","author":"Fournier","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1136\/ard.2007.069831_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/08916939209150321","article-title":"1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL\/l mice","volume":"12","author":"Lemire","year":"1992","journal-title":"Autoimmunity"},{"key":"10.1136\/ard.2007.069831_bib9","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA"},{"key":"10.1136\/ard.2007.069831_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-55580-0_1","article-title":"Evolution and function of vitamin D","volume":"164","author":"Holick","year":"2003","journal-title":"Recent Results Cancer Res"},{"key":"10.1136\/ard.2007.069831_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pbiomolbio.2006.02.016","article-title":"Vitamin D physiology","volume":"92","author":"Lips","year":"2006","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1136\/ard.2007.069831_bib12","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1111\/j.1753-4887.1998.tb01686.x","article-title":"Mechanisms and functions of vitamin D","volume":"56","author":"DeLuca","year":"1998","journal-title":"Nutr Rev"},{"key":"10.1136\/ard.2007.069831_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/sj.ki.5000091","article-title":"New insights into mineral and skeletal regulation by active forms of vitamin D","volume":"69","author":"Hendy","year":"2006","journal-title":"Kidney Int"},{"key":"10.1136\/ard.2007.069831_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ajcn\/60.4.619","article-title":"McCollum Award Lecture, 1994. Vitamin D: new horizons for the 21st century,","volume":"60","author":"Holick","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"10.1136\/ard.2007.069831_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pbiomolbio.2006.02.014","article-title":"Vitamin D: its role in cancer prevention and treatment","volume":"92","author":"Holick","year":"2006","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1136\/ard.2007.069831_bib16","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood-2002-11-3521","article-title":"Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells","volume":"102","author":"Fritsche","year":"2003","journal-title":"Blood"},{"key":"10.1136\/ard.2007.069831_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1523-1755.2000.00202.x","article-title":"Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages","volume":"58","author":"Monkawa","year":"2000","journal-title":"Kidney Int"},{"key":"10.1136\/ard.2007.069831_bib18","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.4049\/jimmunol.170.11.5382","article-title":"Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells","volume":"170","author":"Hewison","year":"2003","journal-title":"J Immunol"},{"key":"10.1136\/ard.2007.069831_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/07315724.2006.10719556","article-title":"How much vitamin D3 do the elderly need?","volume":"25","author":"Viljakainen","year":"2006","journal-title":"J Am Coll Nutr"},{"key":"10.1136\/ard.2007.069831_bib20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00198-005-1867-7","article-title":"Estimates of optimal vitamin D status","volume":"16","author":"Dawson-Hughes","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1136\/ard.2007.069831_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jsbmb.2004.03.038","article-title":"Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults","volume":"89\u201390","author":"Vieth","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1136\/ard.2007.069831_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","article-title":"Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes","volume":"84","author":"Bischoff-Ferrari","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1136\/ard.2007.069831_bib23","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1177\/153537020422901108","article-title":"Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence","volume":"229","author":"Cantorna","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1136\/ard.2007.069831_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0300-483X(02)00257-3","article-title":"Ultraviolet radiation and autoimmune disease: insights from epidemiological research","volume":"181\u2013182","author":"Ponsonby","year":"2002","journal-title":"Toxicology"},{"key":"10.1136\/ard.2007.069831_bib25","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","article-title":"1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis","volume":"93","author":"Cantorna","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2007.069831_bib26","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/ajcn\/80.6.1678S","article-title":"Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease","volume":"80","author":"Holick","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1136\/ard.2007.069831_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2005.05.009","article-title":"Vitamin D deficiency in systemic lupus erythematosus","volume":"5","author":"Kamen","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard.2007.069831_bib28","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jcb.10580","article-title":"The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells","volume":"89","author":"Mahon","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1136\/ard.2007.069831_bib29","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.133.4.1748","article-title":"1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation","volume":"133","author":"Bhalla","year":"1984","journal-title":"J Immunol"},{"key":"10.1136\/ard.2007.069831_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jcb.240490106","article-title":"Immunomodulatory role of 1,25-dihydroxyvitamin D3","volume":"49","author":"Lemire","year":"1992","journal-title":"J Cell Biochem"},{"key":"10.1136\/ard.2007.069831_bib31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO;2-Q","article-title":"Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3)","volume":"30","author":"Mattner","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.2007.069831_bib32","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"J Immunol"},{"key":"10.1136\/ard.2007.069831_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","article-title":"Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts","volume":"97","author":"van Etten","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1136\/ard.2007.069831_bib34","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.4049\/jimmunol.160.11.5314","article-title":"1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4","volume":"160","author":"Cantorna","year":"1998","journal-title":"J Immunol"},{"key":"10.1136\/ard.2007.069831_bib35","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4049\/jimmunol.168.3.1181","article-title":"1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells","volume":"168","author":"Staeva-Vieira","year":"2002","journal-title":"J Immunol"},{"key":"10.1136\/ard.2007.069831_bib36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1440-1711.80.4august.1.x","article-title":"1alpha,25-Dihydroxyvitamin D3 inhibits pro-inflammatory cytokine and chemokine expression in human corneal epithelial cells colonized with Pseudomonas aeruginosa 5","volume":"80","author":"Xue","year":"2002","journal-title":"Immunol Cell Biol"},{"key":"10.1136\/ard.2007.069831_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.icb.7100035","article-title":"Th17 cells: an orphan with influence 4","volume":"85","author":"Stockinger","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"10.1136\/ard.2007.069831_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/clim.2000.4998","article-title":"Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC","volume":"99","author":"Linker-Israeli","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1136\/ard.2007.069831_bib39","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1998.78.4.1193","article-title":"Current understanding of the molecular actions of vitamin D","volume":"78","author":"Jones","year":"1998","journal-title":"Physiol Rev"},{"key":"10.1136\/ard.2007.069831_bib40","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1073\/pnas.121172198","article-title":"Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo","volume":"98","author":"Griffin","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2007.069831_bib41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0301-472X(00)00143-0","article-title":"1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro","volume":"28","author":"Berer","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1136\/ard.2007.069831_bib42","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","article-title":"1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation","volume":"164","author":"Penna","year":"2000","journal-title":"J Immunol"},{"key":"10.1136\/ard.2007.069831_bib43","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1006\/bbrc.2000.2490","article-title":"Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs","volume":"270","author":"Griffin","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ard.2007.069831_bib44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1172\/JCI1050","article-title":"Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene","volume":"101","author":"D'Ambrosio","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2007.069831_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cellimm.2005.04.013","article-title":"Intervention in autoimmunity: the potential of vitamin D receptor agonists","volume":"233","author":"Adorini","year":"2005","journal-title":"Cell Immunol"},{"key":"10.1136\/ard.2007.069831_bib46","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4049\/jimmunol.174.1.270","article-title":"Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis","volume":"174","author":"Gauzzi","year":"2005","journal-title":"J Immunol"},{"key":"10.1136\/ard.2007.069831_bib47","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.4049\/jimmunol.174.4.2061","article-title":"TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells","volume":"174","author":"Lyakh","year":"2005","journal-title":"J Immunol"},{"issue":"Suppl 4","key":"10.1136\/ard.2007.069831_bib48","doi-asserted-by":"crossref","first-page":"iv86","DOI":"10.1136\/ard.2005.044560","article-title":"Dendritic cells: potential triggers of autoimmunity and targets for therapy","volume":"64","author":"Hardin","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.069831_bib49","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1182\/blood-2005-03-1029","article-title":"1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation","volume":"106","author":"Helming","year":"2005","journal-title":"Blood"},{"key":"10.1136\/ard.2007.069831_bib50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/jcb.240550404","article-title":"Regulation of TNF-alpha release from bone marrow-derived macrophages by vitamin D","volume":"55","author":"Abu-Amer","year":"1994","journal-title":"J Cell Biochem"},{"key":"10.1136\/ard.2007.069831_bib51","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1017\/S0950268806007175","article-title":"Epidemic influenza and vitamin D","volume":"134","author":"Cannell","year":"2006","journal-title":"Epidemiol Infect"},{"key":"10.1136\/ard.2007.069831_bib52","first-page":"5624","article-title":"Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues","volume":"44","author":"Koeffler","year":"1984","journal-title":"Cancer Res"},{"key":"10.1136\/ard.2007.069831_bib53","first-page":"11","article-title":"Induction of a high phagocytic capability in P388D1, a macrophage-like tumor cell line, by 1 alpha, 25-dihydroxyvitamin D3","volume":"44","author":"Goldman","year":"1984","journal-title":"Cancer Res"},{"key":"10.1136\/ard.2007.069831_bib54","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1128\/MCB.19.6.4191","article-title":"A two-hit mechanism for vitamin D3-mediated transcriptional repression of the granulocyte-macrophage colony-stimulating factor gene: vitamin D receptor competes for DNA binding with NFAT1 and stabilizes c-Jun","volume":"19","author":"Towers","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1136\/ard.2007.069831_bib55","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1079\/BJN2003837","article-title":"Vitamin D in preventive medicine: are we ignoring the evidence?","volume":"89","author":"Zittermann","year":"2003","journal-title":"Br J Nutr"},{"key":"10.1136\/ard.2007.069831_bib56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2249.2000.01204.x","article-title":"Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages","volume":"120","author":"Overbergh","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2007.069831_bib57","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.intimp.2006.01.018","article-title":"Interaction among vitamin D(3) analogue KH 1060, TNF-alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients","volume":"6","author":"Stio","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1136\/ard.2007.069831_bib58","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1172\/JCI0212392","article-title":"Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice","volume":"109","author":"O'Kelly","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2007.069831_bib59","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2337\/diabetes.49.3.504","article-title":"Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans","volume":"49","author":"Pani","year":"2000","journal-title":"Diabetes"},{"key":"10.1136\/ard.2007.069831_bib60","first-page":"4639","article-title":"Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population","volume":"85","author":"Ban","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1136\/ard.2007.069831_bib61","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/eje.0.1470635","article-title":"Vitamin D receptor genotype is associated with Addison's disease","volume":"147","author":"Pani","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1136\/ard.2007.069831_bib62","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00296-006-0106-7","article-title":"Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis","volume":"26","author":"Rass","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.2007.069831_bib63","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/aje\/kwj278","article-title":"Meta-analysis of vitamin d receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies","volume":"164","author":"Guo","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1136\/ard.2007.069831_bib64","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2337\/diabetes.53.10.2709","article-title":"Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes","volume":"53","author":"Nejentsev","year":"2004","journal-title":"Diabetes"},{"key":"10.1136\/ard.2007.069831_bib65","first-page":"423","article-title":"The modulatory role of melatonin on immune responsiveness","volume":"7","author":"Carrillo-Vico","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1136\/ard.2007.069831_bib66","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/ENDO:27:2:189","article-title":"A review of the multiple actions of melatonin on the immune system","volume":"27","author":"Carrillo-Vico","year":"2005","journal-title":"Endocrine"},{"key":"10.1136\/ard.2007.069831_bib67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pbiomolbio.2006.02.020","article-title":"Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease","volume":"92","author":"Cantorna","year":"2006","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1136\/ard.2007.069831_bib68","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJM199109263251306","article-title":"Inflammatory bowel disease (1)","volume":"325","author":"Podolsky","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2007.069831_bib69","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0016-5085(91)90468-Z","article-title":"Epidemiology of inflammatory bowel disease among U.S. military veterans","volume":"101","author":"Sonnenberg","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1136\/ard.2007.069831_bib70","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/003655202753416876","article-title":"Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease","volume":"37","author":"Jahnsen","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1136\/ard.2007.069831_bib71","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1046\/j.1365-2036.2002.01363.x","article-title":"Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease","volume":"16","author":"Lamb","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1136\/ard.2007.069831_bib72","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/me.2003-0281","article-title":"A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases","volume":"17","author":"Froicu","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1136\/ard.2007.069831_bib73","first-page":"230","article-title":"Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence?","volume":"223","author":"Cantorna","year":"2000","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1136\/ard.2007.069831_bib74","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.106.107599","article-title":"The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates Th1-mediated colitis in mice","author":"Daniel","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1136\/ard.2007.069831_bib75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3181\/00379727-216-44153A","article-title":"Vitamin D and multiple sclerosis","volume":"216","author":"Hayes","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1136\/ard.2007.069831_bib76","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-0447.1960.tb08674.x","article-title":"Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables","volume":"35","author":"Acheson","year":"1960","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1136\/ard.2007.069831_bib77","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","article-title":"High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis","volume":"44","author":"Nieves","year":"1994","journal-title":"Neurology"},{"key":"10.1136\/ard.2007.069831_bib78","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","article-title":"Vitamin D intake and incidence of multiple sclerosis","volume":"62","author":"Munger","year":"2004","journal-title":"Neurology"},{"key":"10.1136\/ard.2007.069831_bib79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0306-9877(86)90010-1","article-title":"Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D","volume":"21","author":"Goldberg","year":"1986","journal-title":"Med Hypotheses"},{"key":"10.1136\/ard.2007.069831_bib80","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jada.2005.12.009","article-title":"Vitamin D and autoimmune disease-implications for practice from the multiple sclerosis literature","volume":"106","author":"Mark","year":"2006","journal-title":"J Am Diet Assoc"},{"key":"10.1136\/ard.2007.069831_bib81","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1191\/096120399678847704","article-title":"Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs, Nurture","volume":"8","author":"Alarcon","year":"1999","journal-title":"Lupus"},{"key":"10.1136\/ard.2007.069831_bib82","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1651-2227.1979.tb04969.x","article-title":"Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus","volume":"68","author":"O'Regan","year":"1979","journal-title":"Acta Paediatr Scand"},{"key":"10.1136\/ard.2007.069831_bib83","first-page":"2535","article-title":"Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia","volume":"28","author":"Huisman","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.069831_bib84","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF02207671","article-title":"Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus","volume":"14","author":"Muller","year":"1995","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2007.069831_bib85","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000045635","article-title":"Vitamin-D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus","volume":"85","author":"Ozaki","year":"2000","journal-title":"Nephron"},{"key":"10.1136\/ard.2007.069831_bib86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1191\/0961203302lu143oa","article-title":"Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus","volume":"11","author":"Huang","year":"2002","journal-title":"Lupus"},{"key":"10.1136\/ard.2007.069831_bib87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3177\/jnsv.36.21","article-title":"Prevention of immunological disorders in MRL\/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin D3","volume":"36","author":"Abe","year":"1990","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"10.1136\/ard.2007.069831_bib88","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(01)06580-1","article-title":"Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study","volume":"358","author":"Hypponen","year":"2001","journal-title":"Lancet"},{"key":"10.1136\/ard.2007.069831_bib89","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s001250051112","article-title":"Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group","volume":"42","author":"Anon","year":"1999","journal-title":"Diabetologia"},{"key":"10.1136\/ard.2007.069831_bib90","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.2337\/diacare.26.12.3237","article-title":"In utero dietary exposures and risk of islet autoimmunity in children","volume":"26","author":"Fronczak","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1136\/ard.2007.069831_bib91","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2337\/diab.41.11.1491","article-title":"1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice","volume":"41","author":"Mathieu","year":"1992","journal-title":"Diabetes"},{"key":"10.1136\/ard.2007.069831_bib92","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s001980070052","article-title":"Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density","volume":"11","author":"Aguado","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1136\/ard.2007.069831_bib93","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/rheumatology\/38.9.841","article-title":"Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis","volume":"38","author":"Oelzner","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 1","key":"10.1136\/ard.2007.069831_bib94","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s003930070035","article-title":"[Vitamin D metabolites in rheumatoid arthritis: findings-hypotheses-consequences]","volume":"59","author":"Hein","year":"2000","journal-title":"Z Rheumatol"},{"key":"10.1136\/ard.2007.069831_bib95","first-page":"453","article-title":"Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients","volume":"17","author":"Andjelkovic","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2007.069831_bib96","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1399-3038.2006.00456.x","article-title":"The vitamin D slant on allergy","volume":"17","author":"Wjst","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1136\/ard.2007.069831_bib97","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1542\/peds.114.1.27","article-title":"Early infant multivitamin supplementation is associated with increased risk for food allergy and asthma","volume":"114","author":"Milner","year":"2004","journal-title":"Pediatrics"},{"key":"10.1136\/ard.2007.069831_bib98","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1337.013","article-title":"Infant vitamin D supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966","volume":"1037","author":"Hypponen","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1136\/ard.2007.069831_bib99","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.4049\/jimmunol.173.5.3432","article-title":"Vitamin D receptor-deficient mice fail to develop experimental allergic asthma","volume":"173","author":"Wittke","year":"2004","journal-title":"J Immunol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724346783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724346783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.069831","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T19:32:49Z","timestamp":1736105569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724346783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":99,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0003496724346783"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.069831","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D and autoimmunity: new aetiological and therapeutic considerations","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.069831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Copyright 2007 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}